MedPath

Face Masks to Reduce the Adverse Effects of Diesel Exhaust Inhalation

Not Applicable
Completed
Conditions
Healthy
Interventions
Other: Diesel exhaust exposure with sham mask
Other: Diesel exhaust exposure with filtered facemask
Registration Number
NCT02729129
Lead Sponsor
Umeå University
Brief Summary

Air pollution exposure is a major environmental and public health concern. The findings from controlled exposure studies have given biological plausibility to the epidemiological associations, and have defined important pathways that may be amenable to intervention. Ultimately, there is a need to address how one may protect the public from these detrimental effects. Two studies have been performed assessing the cardiovascular effects of wearing a face mask in a highly polluted urban area in China in healthy volunteers and patients with coronary heart disease. These demonstrated lower blood pressure and increased heart rate variability when wearing a face mask as compared to not. The investigators aim to test if wearing a highly efficient face mask during exposure to dilute diesel exhaust abrogates the well-known adverse cardiovascular effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
22
Inclusion Criteria
  • Healthy males
  • Non-smoking
  • All subjects undergo a general health examination and are required to have normal clinical examination, ECG, blood tests and lung function
Exclusion Criteria
  • Metabolic or cardiovascular disease
  • Asthma or other respiratory disease
  • Respiratory infection within 2 weeks of the study
  • Antioxidant- and/or vitamin supplementation within 1 week prior to, as well as during the course of the study. (incl vitamin C, Acetylcysteine)
  • Smokers or regular snus usage

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Sham facemaskDiesel exhaust exposure with sham mask-
Commercially available highly-efficient facemaskDiesel exhaust exposure with filtered facemask-
Primary Outcome Measures
NameTimeMethod
Vascular vasomotor function2 hours

Forearm venous occlusion plethysmography to measure forearm blood flow during unilateral intrabrachial infusion of endothelial-dependent and -independent vasodilators. Assessment is shown in ml/100ml tissue/min.

Secondary Outcome Measures
NameTimeMethod
Fibrinolytic function2 hours

Tissue plasminogen activator was analysed in blood samples taken after bradykinin infusions in order to assess fibrinolytic function (ng/ml).

Blood pressure24 hours

Ambulatory blood pressure monitors are worn by subjects for 24 hours during and after exposure.

Heart rate variability24 hours

Holter ECGs are worn by subjects during and for 24 hours post exposure. This will be assessed for heart rate variability (HRV).

Trial Locations

Locations (1)

Umeå University

🇸🇪

Umeå, Sweden

© Copyright 2025. All Rights Reserved by MedPath